Skip to content
healthcare.dev

Rolaids MAX STRENGTH 1500

NDC 84126-373, Calcium carbonate, Magnesium hydroxide, tablet, chewable, from THE PROCTER & GAMBLE MANUFACTURING COMPANY.

Product NDC
84126-373
Status
Listed
Labeler
THE PROCTER & GAMBLE MANUFACTURING COMPANY
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84126-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM CARBONATE1250 mg/1
  • MAGNESIUM HYDROXIDE250 mg/1

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
84126-373-01841260373018 TABLET, CHEWABLE in 1 PACKAGE (84126-373-01)
84126-373-03841260373033 PACKAGE in 1 CELLO PACK (84126-373-03) / 8 TABLET, CHEWABLE in 1 PACKAGE (84126-373-01)
84126-373-508412603735050 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (84126-373-50)
84126-373-53841260373533 BOTTLE, PLASTIC in 1 CELLO PACK (84126-373-53) / 50 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (84126-373-50)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 84126-373 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84126-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84126-373. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.